Skip to main content
Log in

Radiolanthanide-labeled HA particles in the treatment of rheumatoid arthritis: ready-to-use cold kits for rapid formulation in hospital radiopharmacy

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Hydroxyapatite (HA) [Ca10(PO4)6(OH)2] particles radiolabeled with a variety of β emitting lanthanide radionuclides and also pseudolanthanide 90Y have been proposed for the treatment of arthritis. A ready-to-use cold kit of HA particles (1–10 µm size) was developed for fast and convenient formulation of radiolanthanide-labeled HA particles at hospital radiopharmacy. Six radionuclides namely, 169Er, 177Lu, 153Sm, 166Ho, 142Pr and 90Y, having β emissions of a wide range of energy [Eβ(max) = 0.34–2.28 MeV] were identified and produced by thermal neutron activation. Clinical doses of HA particles labeled with these radionuclides were prepared in high yield (>97 %) and radiochemical purity (>99 %) using the cold kits. Pre-clinical studies of 177Lu–HA carried out in Wistar rats bearing arthritis in knee joints revealed no leakage of the activity from the joints. In preliminary clinical investigation using 333 ± 46 MBq doses of the same preparation, significant improvement in the disease conditions was reported in patients with chronic rheumatoid arthritis of knee joints.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Schneider P, Farahati J, Reiners C (2005) J Nucl Med 46:48S–54S

    Google Scholar 

  2. Chinol M, Vallabhajosula S, Goldsmith SJ, Klein MJ, Deutsch KF, Chinen LK, Brodack JW, Deutsch EA, Watson BA, Tofe AJ (1993) J Nucl Med 34:1536–1542

    CAS  Google Scholar 

  3. Deutsch E, Brodack JW, Deutsch KF (1993) Eur J Nucl Med 20:1113–1127

    Article  CAS  Google Scholar 

  4. Siegel ME, Siegal HJ, Luck JV (1997) Semin Nucl Med 4:364–371

    Article  Google Scholar 

  5. Unni PR, Chaudhari PR, Venkatesh M, Ramamoorthy N, Pillai MRA (2002) Nucl Med Biol 29:199–209

    Article  CAS  Google Scholar 

  6. Mawani Y, Cawthray JF, Chang S, Sachs-Barrable K, Weekes DM, Wasan KM, Orvig C (2013) Dalton Trans 42:5999–6011

    Article  CAS  Google Scholar 

  7. Clunie G, Lui D, Cullum I, Edwards JCW, Ell PJ (1995) J Nucl Med 36:51–57

    CAS  Google Scholar 

  8. Pandey U, Mukherjee A, Chaudhary PR, Pillai MR, Venkates M (2001) Appl Radiat Isot 55:471–475

    Article  CAS  Google Scholar 

  9. Bakht MK, Sadeghi M (2011) Anal Nucl Med 25:529–535

    Article  Google Scholar 

  10. Chakraborty S, Das T, Banerjee S, Subramanian S, Sarma HD, Venkatesh M (2006) Nucl Med Biol 33:585–591

    Article  CAS  Google Scholar 

  11. Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M (2006) Nucl Med Commun 27:661–668

    Article  Google Scholar 

  12. Abbasi IA, Ishfaq MM, Sohaib M (2011) Q J Nucl Med Mol Imaging 55:58–468

    Google Scholar 

  13. Chakraborty S, Das T, Chiraiyal V, Lohar SP, Sarma HD (2014) Radiochim Acta 102:443–450

    CAS  Google Scholar 

  14. Pandey U, Dhami PS, Jagesia P, Venkathesh M, Pillai MRA (2008) Anal Chem 80:81–807

    Article  Google Scholar 

  15. Pandey U, Kumar Y, Dash A (2014) J Radioanal Nucl Chem 300:355–360

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Research at the Bhabha Atomic Research Centre is part of the ongoing activities of the Department of Atomic Energy, India and fully supported by government funding. The authors are grateful to Dr. Gursharan Singh, Head, Isotope Application and Radiopharmaceuticals Division, Bhabha Atomic Research Centre, for his support and encouragement. The authors are also thankful to the staff members of Irradiation Co-ordination Group of Isotope Application and Radiopharmaceuticals Division for their help.

Conflict of interest

The authors declare that they have no conflict of interests, financial, scientific or otherwise with other people or organizations in the publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sudipta Chakraborty.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chakraborty, S., Vimalnath, K.V., Rajeswari, A. et al. Radiolanthanide-labeled HA particles in the treatment of rheumatoid arthritis: ready-to-use cold kits for rapid formulation in hospital radiopharmacy. J Radioanal Nucl Chem 302, 875–881 (2014). https://doi.org/10.1007/s10967-014-3309-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-014-3309-5

Keywords

Navigation